These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 597586)

  • 21. In vivo metabolism of (+)-trans-delta-9-tetrahydrocannabinol in the mouse.
    Harvey DJ
    Biomed Environ Mass Spectrom; 1988 Jan; 15(2):117-22. PubMed ID: 2832023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro metabolism of cannabinol in rat, mouse, rabbit, guinea pig, hamster, gerbil and cat.
    Brown NK; Harvey DJ
    Eur J Drug Metab Pharmacokinet; 1990; 15(3):253-8. PubMed ID: 2253656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutral in vivo metabolites of cannabinol isolated from rat faeces.
    Yisak WA; Widman M; Lindgren JE; Agurell S
    J Pharm Pharmacol; 1977 Aug; 29(8):487-90. PubMed ID: 19598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dioxygenated metabolites of cannabidiol formed by rat liver.
    Martin B; Agurell S; Nordqvist M; Lindgren JE
    J Pharm Pharmacol; 1976 Aug; 28(8):603-8. PubMed ID: 11306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Vitro Inhibition of Carboxylesterase 1 by Major Cannabinoids and Selected Metabolites.
    Qian Y; Wang X; Markowitz JS
    Drug Metab Dispos; 2019 May; 47(5):465-472. PubMed ID: 30833288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of pH and temperature on the in vitro bindings of delta-9-tetrahydrocannabinol and other cannabinoids to bovine serum albumin.
    Papa VM; Shen ML; Ou DW
    J Pharm Biomed Anal; 1990; 8(4):353-6. PubMed ID: 1966044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.
    Agurell S; Carlsson S; Lindgren JE; Ohlsson A; Gillespie H; Hollister L
    Experientia; 1981 Oct; 37(10):1090-2. PubMed ID: 6273208
    [No Abstract]   [Full Text] [Related]  

  • 28. Behaviour in rats maintained by low differential reinforcement rate: effects of delta 1-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination.
    Hiltunen AJ; Järbe TU; Kamkar MR; Archer T
    Neuropharmacology; 1989 Feb; 28(2):183-9. PubMed ID: 2541367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of metabolites of delta1- and delta1(6)-tetrahydrocannabinol containing a reduced double bond.
    Harvey DJ; Martin BR; Paton WD
    J Pharm Pharmacol; 1977 Aug; 29(8):495-7. PubMed ID: 19600
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative metabolism of cannabidiol in dog, rat and man.
    Harvey DJ; Samara E; Mechoulam R
    Pharmacol Biochem Behav; 1991 Nov; 40(3):523-32. PubMed ID: 1806942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of the butyl homologues of delta1-tetrahydrocannabinol, cannabinol and cannabidiol in samples of cannabis by combined gas chromatography and mass spectrometry.
    Harvey DJ
    J Pharm Pharmacol; 1976 Apr; 28(4):280-5. PubMed ID: 6715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. UDP-glucuronyltransferase activities of rabbit liver microsomes for cannabinoids.
    Watanabe K; Yamamoto I; Oguri K; Yoshimura H
    J Pharmacobiodyn; 1980 Sep; 3(9):482-4. PubMed ID: 6780681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.
    Huestis MA
    Handb Exp Pharmacol; 2005; (168):657-90. PubMed ID: 16596792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. I. In vivo investigation of the primary and secondary immune response.
    Baczynsky WO; Zimmerman AM
    Pharmacology; 1983; 26(1):1-11. PubMed ID: 6298841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dihydroxylated metabolites of cannabinol formed by rat liver in vitro.
    Fonseka K; Widman M
    J Pharm Pharmacol; 1977 Jan; 29(1):12-4. PubMed ID: 13175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of monohydroxylated metabolites of cannabidiol formed by rat liver.
    Martin B; Nordqvist M; Agurell S; Lindgren JE; Leander K; Binder M
    J Pharm Pharmacol; 1976 Apr; 28(4):275-9. PubMed ID: 6714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry.
    Desrosiers NA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2015 Aug; 7(8):684-94. PubMed ID: 25428610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
    Hiltunen AJ; Järbe TU
    Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of delta 9-tetrahydrocannabinol, cannabinol and cannabidiol on the immune system in mice. II. In vitro investigation using cultured mouse splenocytes.
    Baczynsky WO; Zimmerman AM
    Pharmacology; 1983; 26(1):12-9. PubMed ID: 6298842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro metabolism of cannabigerol in several mammalian species.
    Harvey DJ; Brown NK
    Biomed Environ Mass Spectrom; 1990 Sep; 19(9):545-53. PubMed ID: 2224182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.